Article
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts.
Journal for immunotherapy of cancer - 27 Feb 2024
Perez-Penco Maria, Lara de la Torre Lucia, Lecoq Inés, Martinenaite Evelina, Andersen Mads Hald
Abstract excerpt
The tumor microenvironment (TME) of pancreatic cancer is highly immunosuppressive. We recently developed a transforming growth factor (TGF)β-based immune modulatory vaccine that controlled tumor growth in a murine model of pancreatic cancer by targeting immunosuppression and desmoplasia in the TME. We found that treatment with the TGFβ vaccine not only reduced the percentage of M2-like tumor-associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
